TikTok Influencers Driving Unofficial Market for Unlicensed Slimming Drug
An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.
Some professionals said the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Material Elimination
Based on TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures.
Online Trading Operations
Investigations also found communities with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, glowing testimonials and detailed instructions for preparing or administering at home.
After minutes of joining one community, a vendor posted contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.
Product Information and Pricing
Within these communities, messages show black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly serious medical dangers”.
